LifeStance Health Group (NASDAQ:LFST) Director Robert Bessler Sells 119,942 Shares

by · The Markets Daily

LifeStance Health Group, Inc. (NASDAQ:LFST – Get Free Report) Director Robert Bessler sold 119,942 shares of the company’s stock in a transaction on Friday, December 19th. The stock was sold at an average price of $7.04, for a total transaction of $844,391.68. Following the transaction, the director owned 1,318,983 shares of the company’s stock, valued at approximately $9,285,640.32. This represents a 8.34% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.

Robert Bessler also recently made the following trade(s):

  • On Monday, December 22nd, Robert Bessler sold 1,701 shares of LifeStance Health Group stock. The shares were sold at an average price of $7.04, for a total transaction of $11,975.04.
  • On Thursday, December 18th, Robert Bessler sold 6,442 shares of LifeStance Health Group stock. The stock was sold at an average price of $7.00, for a total value of $45,094.00.
  • On Monday, December 15th, Robert Bessler sold 12,371 shares of LifeStance Health Group stock. The shares were sold at an average price of $7.00, for a total transaction of $86,597.00.
  • On Friday, December 12th, Robert Bessler sold 79,630 shares of LifeStance Health Group stock. The shares were sold at an average price of $7.01, for a total transaction of $558,206.30.

LifeStance Health Group Trading Up 0.1%

Shares of NASDAQ:LFST traded up $0.01 during trading on Tuesday, hitting $7.06. The company had a trading volume of 1,276,911 shares, compared to its average volume of 2,381,689. The company has a debt-to-equity ratio of 0.18, a current ratio of 1.58 and a quick ratio of 1.58. The company has a fifty day simple moving average of $6.07 and a two-hundred day simple moving average of $5.38. The stock has a market cap of $2.75 billion, a price-to-earnings ratio of -235.33 and a beta of 1.13. LifeStance Health Group, Inc. has a one year low of $3.74 and a one year high of $8.30.

LifeStance Health Group (NASDAQ:LFST – Get Free Report) last released its earnings results on Wednesday, November 5th. The company reported $0.02 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.01) by $0.03. The firm had revenue of $363.81 million during the quarter, compared to analyst estimates of $355.06 million. LifeStance Health Group had a negative net margin of 0.67% and a negative return on equity of 0.62%. The business’s revenue was up 16.3% on a year-over-year basis. During the same quarter last year, the business earned ($0.02) EPS. As a group, equities analysts forecast that LifeStance Health Group, Inc. will post -0.18 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on the stock. BMO Capital Markets began coverage on shares of LifeStance Health Group in a research report on Thursday, November 13th. They issued an “outperform” rating and a $8.00 price target for the company. Weiss Ratings reiterated a “sell (d-)” rating on shares of LifeStance Health Group in a research note on Monday. UBS Group lifted their target price on LifeStance Health Group from $9.00 to $10.00 and gave the stock a “buy” rating in a report on Friday, November 7th. Barclays initiated coverage on LifeStance Health Group in a research report on Tuesday, December 9th. They issued an “overweight” rating and a $8.00 target price on the stock. Finally, Wall Street Zen lowered shares of LifeStance Health Group from a “buy” rating to a “hold” rating in a research report on Saturday, October 11th. Two analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $8.83.

Check Out Our Latest Research Report on LifeStance Health Group

Institutional Trading of LifeStance Health Group

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Jacobs Levy Equity Management Inc. acquired a new position in LifeStance Health Group in the 1st quarter valued at $7,932,000. Squarepoint Ops LLC boosted its stake in LifeStance Health Group by 259.1% during the 2nd quarter. Squarepoint Ops LLC now owns 1,360,054 shares of the company’s stock worth $7,031,000 after purchasing an additional 981,349 shares during the last quarter. Adage Capital Partners GP L.L.C. raised its position in shares of LifeStance Health Group by 43.8% in the first quarter. Adage Capital Partners GP L.L.C. now owns 230,000 shares of the company’s stock valued at $1,532,000 after buying an additional 70,000 shares during the last quarter. AXQ Capital LP purchased a new position in shares of LifeStance Health Group in the second quarter worth about $343,000. Finally, TD Asset Management Inc acquired a new position in LifeStance Health Group during the second quarter worth about $780,000. Hedge funds and other institutional investors own 85.50% of the company’s stock.

About LifeStance Health Group

(Get Free Report)

LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.

Further Reading